NRG Oncology/RTOG 0415, hypofractionation in patients with low-risk prostate cancer: are patient reported outcomes the practice change tipping point?

被引：0
|
作者：
Pugh, Stephanie L. [1 ]
Lee, W. R. [2 ]
Dignam, James [1 ]
Low, Daniel [3 ]
Swanson, Gregory P. [4 ]
Shah, Amit B. [5 ]
D'Souza, David P. [6 ]
Michalski, Jeff M. [7 ]
Dayes, Ian S. [8 ]
Seaward, Samantha A. [9 ]
Nguyen, Paul L. [10 ]
Hall, William A. [11 ]
Pisansky, Thomas M. [12 ]
Chen, Yuhchyau [13 ]
Sandler, Howard M. [14 ]
Movsas, Benjamin [15 ]
Bruner, Deborah W. [16 ]
机构：
[1] NRG Oncol, Philadelphia, PA USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[5] WellSpan Hlth York Canc Ctr, York, PA USA
[6] London Reg Canc Program, London, ON, Canada
[7] Washington Univ, St Louis, MO USA
[8] McMaster Univ, Juravinski Canc Ctr, Hamilton Hlth Sci, Hamilton, ON, Canada
[9] Kaiser Permanente Northern Calif, Santa Clara, CA USA
[10] Dana Farber Harvard Canc Ctr, Boston, MA USA
[11] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[12] Mayo Clin, Scottsdale, AZ USA
[13] Univ Rochester, Rochester, NY USA
[14] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[15] Henry Ford Hosp, Detroit, MI 48202 USA
[16] Emory Univ, Atlanta, GA 30322 USA
来源：
QUALITY OF LIFE RESEARCH | 2017年 / 26卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
206.2
引用
收藏
页码：38 / 39
页数：2
相关论文
共 50 条
  • [41] Feasibility and delivery of patient-reported outcomes in clinical practice among racially diverse bladder and prostate cancer patients
    Smith, Angela B.
    Samuel, Cleo A.
    McCabe, Sean D.
    Deal, Allison
    Jonsson, Mattias
    Mueller, Dana E.
    Mahbooba, Zahra M.
    Bennett, Antonia, V
    Chung, Arlene E.
    Nielsen, Matthew E.
    Tan, Hung-Jui
    Wallen, Eric
    Pruthi, Raj
    Wang, Andrew
    Basch, Ethan
    Reeve, Bryce B.
    Chen, Ronald C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (01) : 77.e1 - 77.e8
  • [42] LOW-RISK PROSTATE CANCER PATIENTS TREATED WITH HYPOFRACTIONATED RADIATION THERAPY: LONG TERM OUTCOMES, TOXICITY AND SEXUAL FUNCTION
    Marinelli, Luca
    Reverberi, Chiara
    Osti, Mattia Falchetto
    De Sanctis, Vitaliana
    Tronnolone, Lidia
    Giuliani, Manuela
    Valeriani, Maurizio
    ANTICANCER RESEARCH, 2018, 38 (04) : 2515 - 2515
  • [43] Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study
    Brooks, Joanna Veazey
    Ellis, Shellie D.
    Morrow, Emily
    Kimminau, Kim S.
    Thrasher, J. Brantley
    AMERICAN JOURNAL OF MENS HEALTH, 2018, 12 (05) : 1719 - 1727
  • [44] The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas
    Xiao Jun Wang
    Denise Yun Ting Goh
    Sreemanee Raaj Dorajoo
    Alexandre Chan
    Supportive Care in Cancer, 2017, 25 : 2815 - 2822
  • [45] The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas
    Wang, Xiao Jun
    Goh, Denise Yun Ting
    Dorajoo, Sreemanee Raaj
    Chan, Alexandre
    SUPPORTIVE CARE IN CANCER, 2017, 25 (09) : 2815 - 2822
  • [46] Conventional vs. Hypofractionation Radiation for High-Risk Prostate Cancer Patients (CHIRP): 24 Months Patient-Reported Quality of Life Outcomes of the Randomized Phase II CHIRP Trial
    Yang, F.
    Ghosh, S.
    Yee, D.
    Patel, S. I.
    Parliament, M. B.
    Usmani, N. H.
    Danielson, B. L.
    Amanie, J.
    Pearcey, R.
    Pederson, J.
    Murtha, A. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S79 - S79
  • [47] PATIENT REPORTED FUNCTIONAL OUTCOMES AFTER 5 YEARS IN MEN WITH LOW- AND FAVORABLE INTERMEDIATE-RISK PROSTATE CANCER
    Joyce, Daniel D.
    Laviana, Aaron A.
    Zhao, Zighuo
    Hoffman, Karen E.
    Huang, Li-Ching
    Koyama, Tatsuki
    Conwill, Ralph
    Penson, David F.
    Barocas, Daniel A.
    JOURNAL OF UROLOGY, 2019, 201 (04): : E562 - E562
  • [48] Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients With Low-Risk Prostate Cancer in the Community Practice
    Gaylis, Franklin D.
    Leapman, Michael S.
    Ellis, Shellie D.
    Hu, Steven
    Cooperberg, Matthew R.
    Loeb, Stacy
    Chen, Ronald C.
    Cohen, Edward S.
    Dato, Paul E.
    Aynehchi, Shahrad
    David, Richard
    Topp, Robert
    Santomauro, Bianca
    Ginsburg, Kevin
    Catalona, William J.
    UROLOGY PRACTICE, 2025, 12 (02) : 241 - 248
  • [49] Integrating weekly symptom monitoring for patients with prostate cancer in radiation oncology: A prospective cohort study using electronic patient-reported outcomes
    Moller, P. K.
    Pappot, H.
    Schytte, T.
    Bernchou, U.
    Dieperink, K. B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1229 - S1229
  • [50] Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202
    Mirhadi, Amin J.
    Zhang, Qiang
    Hanks, Gerald E.
    Lepor, Herbert
    Grignon, David J.
    Peters, Christopher A.
    Rosenthal, Seth A.
    Zeitzer, Kenneth
    Radwan, John S.
    Lawton, Colleen
    Parliament, Matthew B.
    Reznik, Robert S.
    Sandler, Howard M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (03): : 511 - 515
12345